Notice: Prescription Drug List (PDL): Multiple Additions (2020-12-21) (English, HTML)
View metadata and access the original English HTML file: Notice: Prescription Drug List (PDL): Multiple Additions (2020-12-21).
- Format
- HTML
- Access
- file-only
- Publisher-reported update
- 2023-10-01
The purpose of this Notice of Amendment is to notify about the additions of fostamatinib, givosiran, lemborexant, luspatercept, ozanimod, trientine, and voretigene neparvovec to the Prescription Drug List (PDL) for human and veterinary use.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file